Operating Room Orientation Video Education in Patients Undergoing Prostate Surgery

August 18, 2026 updated by: Beyza Çakır, Ondokuz Mayıs University

The Effect of Operating Room Orientation Video Education Applied at Different Times on Postoperative Pain and Anxiety in Patients Undergoing Prostate Surgery

This study aims to evaluate the effect of operating room orientation video education delivered at different time points on postoperative pain and state anxiety in patients undergoing surgery for benign prostatic hyperplasia. Patients undergoing transurethral resection of the prostate or holmium laser enucleation of the prostate will be randomly assigned to one of three groups: video education one day before surgery in the surgical ward, video education approximately 30 minutes before surgery in the operating room waiting unit, or routine preoperative information. Pain and state anxiety will be assessed at predefined preoperative and postoperative time points.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The study will evaluate whether the timing of operating room orientation video education influences postoperative pain and state anxiety in patients undergoing surgery for benign prostatic hyperplasia. The intervention consists of a 5-minute video designed to familiarize patients with the perioperative environment and expected procedures. The video includes information about the operating room environment, the operating table, patient positioning, information related to the surgical process, the post-anesthesia care unit, and patient transfer.

Participants will be randomly allocated in a 1:1:1 ratio to one of three parallel groups. Participants in the first intervention group will receive the video approximately one day before surgery in the surgical ward. Participants in the second intervention group will receive the same video approximately 30 minutes before surgery in the operating room waiting unit. Participants in the control group will receive routine preoperative information according to standard clinical practice.

Pain intensity will be assessed using the Visual Analog Scale, and state anxiety will be assessed using the State-Trait Anxiety Inventory-State Anxiety Scale. Assessments will be performed one day before surgery, before the intervention in the operating room waiting unit, and six hours after surgery in the surgical ward.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
126

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey (Türkiye)
    • Atakum
      • Samsun, Atakum, Turkey (Türkiye), 55500
        • Ondokuz Mayıs University Health Practice and Research Center
        • Contact:
        • Principal Investigator:
          • Beyza Çakır
        • Sub-Investigator:
          • Özge İşeri, Associate professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being conscious and able to communicate. Being able to read and understand Turkish. Voluntarily agreeing to participate in the study and providing informed consent.

Having no visual or hearing impairment that would interfere with viewing the educational video or completing the study assessments.

Undergoing prostate surgery for the first time. Being 18 years of age or older.

Exclusion Criteria:

  • Having a diagnosed psychiatric disorder. Having a chronic pain syndrome. Being scheduled for emergency surgery. Having previously received similar operating room orientation education.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Ward Video Education Group
Participants will receive a 5-minute operating room orientation video approximately one day before surgery in the surgical ward.
Behavioral: Operating Room Orientation Video Education
A 5-minute video-based educational intervention designed to familiarize patients with the operating room environment and the perioperative process. The video includes information about the operating room environment, operating table, patient positioning, information related to the surgical process, the post-anesthesia care unit, and patient transfer.
Experimental: Operating Room Waiting Unit Video Education Group
Participants will receive the same 5-minute operating room orientation video approximately 30 minutes before surgery in the operating room waiting unit.
Behavioral: Operating Room Orientation Video Education
A 5-minute video-based educational intervention designed to familiarize patients with the operating room environment and the perioperative process. The video includes information about the operating room environment, operating table, patient positioning, information related to the surgical process, the post-anesthesia care unit, and patient transfer.
Active Comparator: Routine Information Control Group
Participants will receive routine preoperative information according to standard clinical practice without the study-specific operating room orientation video.
Behavioral: Routine Preoperative Information
Participants will receive routine preoperative information according to standard clinical practice without the study-specific operating room orientation video.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Postoperative state anxiety
Time Frame: From baseline to 6 hours after surgery
State anxiety will be assessed using the State-Trait Anxiety Inventory-State Anxiety Scale (STAI-S), using the Turkish adaptation by Necla Öner and Ayhan Le Compte. State anxiety will be assessed one day before surgery in the surgical ward, before video education in the operating room waiting unit, and 6 hours after surgery in the surgical ward. The primary postoperative assessment will be the STAI-S score at 6 hours after surgery.
From baseline to 6 hours after surgery
Postoperative pain intensity
Time Frame: From baseline to 6 hours after surgery
Pain intensity will be assessed using the Visual Analog Scale (VAS). Pain will be assessed one day before surgery in the surgical ward, before video education in the operating room waiting unit, and 6 hours after surgery in the surgical ward. The primary postoperative assessment will be the VAS score at 6 hours after surgery.
From baseline to 6 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Ondokuz Mayıs University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 1, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 18, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 18, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 21, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 21, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 18, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2025/1127

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be publicly shared to protect participant confidentiality and privacy. Aggregated study results will be reported in the master's thesis and subsequent scientific publications.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings